PMC:7228307 / 1896-2291 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":123,"end":137},"obj":"Body_part"},{"id":"T11","span":{"begin":138,"end":143},"obj":"Body_part"},{"id":"T12","span":{"begin":139,"end":141},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T26","span":{"begin":105,"end":107},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T27","span":{"begin":144,"end":152},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T28","span":{"begin":166,"end":167},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":218,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T3","span":{"begin":123,"end":137},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T4","span":{"begin":139,"end":141},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A3","pred":"meddra_id","subj":"T3","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"},{"id":"A4","pred":"meddra_id","subj":"T4","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T9","span":{"begin":202,"end":206},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T10","span":{"begin":227,"end":236},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"},{"id":"T11","span":{"begin":280,"end":296},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T14","span":{"begin":80,"end":297},"obj":"Sentence"},{"id":"T15","span":{"begin":298,"end":381},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T10","span":{"begin":123,"end":137},"obj":"Body_part"},{"id":"T11","span":{"begin":138,"end":143},"obj":"Body_part"},{"id":"T12","span":{"begin":139,"end":141},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T2","span":{"begin":280,"end":296},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T2","span":{"begin":280,"end":296},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":280,"end":296},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}

{"project":"LitCovid-sentences","denotations":[{"id":"T14","span":{"begin":80,"end":297},"obj":"Sentence"},{"id":"T15","span":{"begin":298,"end":381},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" and its relationship with the present and future actions of therapeutic mAbs.\n\nFragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. The use and m"}